DXCM
DexCom, Inc.
Healthcare
$71.90
as of May 21, 2026
Sign in to add DXCM to your portfolio.
Sign inMarket cap
$27.57B
P/E (TTM)
29.6x
EPS (TTM)
$2.42
Dividend yield
—
Annual financials
| FY | Revenue | Net income | FCF | Gross margin | Op. margin | EPS (diluted) |
|---|---|---|---|---|---|---|
| 2021 | $2.45B | $216.90M | $53.30M | 68.6% | 10.9% | $0.56 |
| 2022 | $2.91B | $341.20M | $304.70M | 64.7% | 13.4% | $0.88 |
| 2023 | $3.62B | $541.50M | $511.90M | 63.2% | 16.5% | $1.44 |
| 2024 | $4.03B | $576.20M | $630.70M | 60.5% | 14.9% | $1.46 |
| 2025 | $4.66B | $836.30M | $1.08B | 60.0% | 19.6% | $2.14 |
Recent prices
| Date | Open | Close | Volume |
|---|---|---|---|
| May 21, 2026 | $71.50 | $71.90 | 9.08M |
| May 20, 2026 | $66.71 | $71.44 | 11.20M |
| May 19, 2026 | $65.28 | $66.95 | 11.30M |
| May 18, 2026 | $61.79 | $65.09 | 13.51M |
| May 15, 2026 | $59.91 | $61.63 | 11.13M |
| May 14, 2026 | $59.02 | $57.82 | 4.32M |
| May 13, 2026 | $60.45 | $58.57 | 7.03M |
| May 12, 2026 | $60.14 | $61.14 | 6.10M |
| May 11, 2026 | $60.34 | $59.33 | 5.27M |
| May 08, 2026 | $60.91 | $60.61 | 4.22M |
| May 07, 2026 | $60.36 | $60.91 | 5.08M |
| May 06, 2026 | $59.71 | $60.36 | 5.91M |
| May 05, 2026 | $60.54 | $59.48 | 5.53M |
| May 04, 2026 | $61.61 | $60.04 | 5.49M |
| May 01, 2026 | $60.99 | $61.35 | 10.56M |
| Apr 30, 2026 | $57.88 | $59.55 | 5.34M |
| Apr 29, 2026 | $58.95 | $57.56 | 6.56M |
| Apr 28, 2026 | $61.68 | $59.32 | 5.59M |
| Apr 27, 2026 | $61.12 | $61.41 | 3.38M |
| Apr 24, 2026 | $62.67 | $61.57 | 3.60M |
| Apr 23, 2026 | $63.09 | $62.70 | 2.51M |
| Apr 22, 2026 | $63.16 | $63.41 | 2.68M |
| Apr 21, 2026 | $64.87 | $62.60 | 4.36M |
| Apr 20, 2026 | $63.57 | $64.62 | 3.77M |
Profitability & balance
- ROE (TTM)
- 33.8%
- Gross margin
- 61.8%
- Operating margin
- 21.4%
- Net margin
- 19.3%
- Debt / equity
- 0.47